image

The best stocks to buy since 1993

Latest issue now available

Regenersis

October 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 56p
Regenersis has announced results for the year to 30 June with an adjusted pretax profit of £5m for eps of 10.5p based on a low tax charge. These are the first results since Regenersis announced a new strategy where it has realigned into three market sectors. Under this segmental analysis, repair of mobile handsets represented two thirds of the £116m sales and the rest splits between repair of media & entertainment and IT. All three increased profitability.The mobile side included a first time contribution from TRS (for 10 months) offset by a continuing worsening position on the environmental services part, which recycles mobile phones. Excluding these two, which contributed profits of £0.7m and £0.5m respectively, the unde ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe